Lombard Odier Asset Management (Switzerland)’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-38,881
Closed -$5.56M 320
2021
Q4
$5.56M Sell
38,881
-13,050
-25% -$2.24M 0.36% 65
2021
Q3
$10.7M Sell
51,931
-57,492
-53% -$12.7M 0.67% 60
2021
Q2
$23.2M Buy
109,423
+43,021
+65% +$7.88M 1.18% 34
2021
Q1
$12M Buy
+66,402
New +$13.2M 0.8% 47

Other funds holding NVAX

Lombard Odier Asset Management (Switzerland)'s NVAX Position: Q1 2022 in Review

Lombard Odier Asset Management (Switzerland) sold out of Novavax (NVAX) in Q1 2022, closing a stake of 38,881 shares — an estimated $5.56M sold.

Lombard Odier Asset Management (Switzerland) first reported a position in NVAX in Q1 2021 and held it in 4 quarters. The position peaked at $23.2M in Q2 2021. 382 funds tracked by Wall St. Rank hold NVAX as of Q1 2022.

  • Lombard Odier Asset Management (Switzerland) reported no remaining Novavax position as of Q1 2022 after selling out during the quarter.
  • Lombard Odier Asset Management (Switzerland) sold 38,881 Novavax shares in Q1 2022, an estimated $5.56M.
  • Lombard Odier Asset Management (Switzerland) first reported a position in Novavax in Q1 2021 and held it in 4 quarters.
  • Lombard Odier Asset Management (Switzerland)'s Novavax position peaked at $23.2M in Q2 2021.
  • 382 funds tracked by Wall St. Rank held Novavax as of Q1 2022.

Based on Lombard Odier Asset Management (Switzerland)'s 13F filing for Q1 2022, filed 16 May 2022.